Connect with us

BUSINESS

Future Farm Technologies Inc (OTCMKTS:FFRMF) Unveils Nextech Spin-Out Details

Published

on

Future Farm Technologies Inc (OTCMKTS:FFRMF) today disclosed important details regarding NexTech AR Solutions Corp. A total of 11,000,000 common shares were span-out and this shouldn’t get anyone by surprise considering that the date had been disclosed earlier on. Asides from that, the terms had also been laid out clearly and thus a successful spin-out was anticipated by many following closely on the matter.

A close outlook

As per the set terms, any shareholder that had been with the company as of August 30, 2018 was set to receive about 0.086145 of each NexTech common share. An official working with NexTech says that anytime soon they might progress to list their shares on CSE. He adds that it isn’t a promise since he is not in a position to guarantee that their shares will be listed on the stock exchange.

He goes on to call upon all the Future Farm shareholders who are looking forward to receive NexTech shares  to make consultations with their brokers regarding particular queries in line with their holdings.

Future Farm has also pronounced its entry into a Conditional Lease Commitment with a specialty finance company called Veterans Capital Corp. This is a business that has over the years focused in the provision financial and leasing services to a wide range of business clients.

Future Farm CEO William Gildea opined, “We are pleased to continue working with Veterans Capital. Veterans’ line of credit provides Future Farm with access to capital that will help to expand our cannabis and industrial hemp extraction business.”

The progress of Future Farm Technologies

Future Farm Technologies has succeeded in making a name for itself in line with the manufacture of both wholesale and retail cannabis products in all the four corners of North America. The President of Veterans Capital Corp Joe Wold has made a statement regarding the company’s Lease Line. According to him, having in place a sound alternative of growth capital was a matter that couldn’t be underestimated.

Shareholders as always hope for the best and the company promises to deal with challenges that might pop up along the way accordingly.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

BUSINESS

BetterLife Pharma Inc. (OTCMKTS: BETRF) Announces Significant Progress in H1 2021

Published

on

There are reportedly more than 265 million people across the globe suffering from depression. Unfortunately, the only available treatment is psychedelics, which again has its drawbacks, including being expensive and unpredictable side effects. This clearly explains a far-fetched unmet need. However, according to BetterLife Pharma Inc. (OTCMKTS: BETRF), it is possible to treat any neurological condition, including depression and related side effects such as hallucinations. Thanks to several human clinical trials in H1 2021. 

The emerging biotech has provided substantial progress concerning H1 2021. The company scaled up the process development for GMP manufacturing. Additionally, there was an execution of several agreements with leading researchers at marquee institutions for preclinical pharmacology. Other IND-enabling studies included Nova Labs- GLP cardiac studies, Eurofins Discovery – Pharmacology and safety, ITR Labs – GLP bioavailability and toxicology, and Comparative in-vitro studies vs. LSD with the University of California San Diego. 

The Development of TD-0148A for Treatment of Major Depressive Disorders

The projection for depressive and neurological disorders, which include a cluster of headaches, stands at nearly US$25 billion by 2030. However, BetterLife’s TD-0148Aa second-generation lysergic acid diethylamide (“LSD”) derivative molecule is believed to be a possible solution. And with a unique and patented manufacturing process, the company has issued patents on the synthesis of this potential treatment. The good news is that, unlike psychedelics, TD-0148A has the potential to overcome several side effects. Additionally, it does not require the presence of a therapist because it is self-administered. 

The company says it is also working on a second compound, TD-010, and is projected to treat benzodiazepine dependency before developing other neurological-related disorders. 

Meanwhile, it is not long ago since BetterLife Pharma Inc. recruited Mr. Henri Sant-Cassia to its Board of Directors. The co-founder of The Conscious Fund has been a serial entrepreneur since his early twenties before joining the plant medicine field. His experience also spreads out to the manufacturing, retail, and research of cannabinoid-based products. This experience in the psychedelic space will be precious in developing non-hallucinogenic compounds for mental health disorders.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Auxly Cannabis Group Inc. (OTCMKTS: CBWTF) Takes over the Summer Season with a Suite of High-Quality and Unique Cannabis Products

Published

on

More Americans will soon access legal cannabis as more states are expected to advance cannabis legalization measures in the coming years. Some of the keys for unlocking the potential of cannabis include continued innovation and execution excellence while building authentic relationships with consumers. That said, a leading consumer packaged goods company in the cannabis market, Auxly Cannabis Group Inc. (OTCMKTS: CBWTF), has announced a new set of product line-ups for the summer season. 

“Canadians deserve something special after a year and a half of pandemic life, and we wanted to make sure our brands rose to the occasion… developers and marketing experts have leveraged consumer insights this summer to bring a suite of high-quality and unique cannabis products…,” Senior Vice President, Commercial, Auxly Andrew MacMillan acknowledged

Use of Focused Strategies to Grow its Market Share 

Auxly’s involvement in a strategic expansion into the dried flower market is quickly birthing results. The company has been riding on success from the dried flower offerings under its Back Forty brand. Through this brand, Auxly bagged almost 2% of the entire national cannabis flower market in June. The total achievement was a 5.2% share of the national market emanating from the successful sale of dried flowers and the company’s leadership position in cannabis 2.0 products. 

According to the CEO, Hugo Alves, they have built on deep consumer insights and execution excellence. They will also continue introducing a more robust line-up of new products in line with the consumer’s needs. A suite of high-quality and unique cannabis products will take center stage this summer; vapes, edibles, oil, capsules, and concentrates, among others, and they are expected to help the company gain meaningful market share. Kolab Project, Back Forty, Foray, and Dosecann are also some of Auxly’s in-house brands the company is about to launch in the coming weeks.  This will come along with unique edible products but for select provinces.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Rubicon Organics Inc. (OTCMKTS: ROMJF) Outlines its Corporate and Operational Highlights Covering the First Half of 2021

Published

on

Have you ever been in a situation of sickness where you felt utterly helpless? The instituting of Rubicon Organics Inc. was at the height of the lack of high-quality, organic cannabis products for medicinal use. Its founders spent several years perfecting the art of organic cannabis greenhouse cultivation, and before long, the company became a household name. It is one of the only six Organic Certified cannabis producers in Canada with Fraser Valley Organic Producers Association (FVOPA) certification. And over the years, the company has invested in innovative and sustainable practices, from using only organic inputs to minimizing its waste and packaging. 

As the Canadian cannabis market continues to increase, Rubicon Organics is also registering incredible milestones. While unveiling its operational update, the company outlined several milestones, including a 132% increase in the number of new products its Q3, 2021. Additionally, the company’s 1964 Supply Co. premium brand was introduced to New Brunswick in June 2021, listing in seven provinces. As well, five provincial distributors accepted Homestead, a mainstream brand developed for the avid cannabis consumer. 

The Organization’s Corporate Highlights Demonstrating Significant Growth Potential

Rubicon Organics is focused on achieving industry-leading profitability and has a keen eye for innovation and the development of brands. Some of its flagship super-premium brands include Simply Bare Organic with a launch of 10 new SKUs and super-premium concentrate brand LAB THEORY, among others. 

In its first half of 2021, the company launched Wildflower CBD Topicals, a closed organic certified extraction services’ deal with The Valens Company. In addition, it stepped into Yukon territory through a Cannabis Purchase and Sale Pact with Cannabis Yukon for the distribution of its cannabis products. 

In other news, Rubicon Organics announced Cannabis Cultivators of B.C. (CCBC), a non-profit industry association. With the incorporation of Pure Sunfarms and Tantalus Labs, CCBC will work with policymakers to advocate for the growth of a responsible cannabis industry in British Columbia (B.C.). This can be viewed as a timely move given the thriving and fast-growing legal cannabis industry in B.C.            

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories